Medicines Australia has submitted its application for authorisation of its 18th Edition of the Code of Conduct to the Australian Competition and Consumer Commission. The Code includes new requirements for reporting of payments to individual doctors.

The submission is in response to ACCC requests in 2012 for full transparency of industry payments to healthcare professionals.  Under the new transparency model, Medicines Australia member companies will be required to seek consent from healthcare professionals before disclosing payments or transfers of value made to them.  However, the Code has been met with some opposition as the voluntary nature of doctor disclosure hinders the apparent ‘transparent’ model in its effectiveness.

The ACCC authorisation process is expected to take six months.  If authorised, the Code will come into effect in January 2015.

To view the Code, click here.